Table of Content



Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Diagnostics Technique
1.2.2. Type
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Diagnostics Technique outlook
2.2.2. Type outlook
2.2.3. End Use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. China Alzheimer’s Disease Diagnostics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of Alzheimer’s disease
3.2.1.2. Increasing use of biomarkers in diagnosis
3.2.1.3. Growing adoption of personalized products
3.2.1.4. Growing R&D studies and Government investments
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulations
3.3. China Alzheimer’s Disease Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTEL Analysis
Chapter 4. China Alzheimer’s Disease Diagnostics Market: Diagnostics Technique Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. China Alzheimer’s Disease Diagnostics Market: Diagnostics Technique Movement Analysis
4.3. China Alzheimer’s Disease Diagnostics Market Size & Trend Analysis, by diagnostic technique, 2018 - 2030 (USD Million)
4.4. Biomarker
4.4.1. Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. CSF Biomarkers
4.4.2.1. CSF Biomarkers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Blood Based Biomarker
4.4.3.1. Blood Based Biomarker Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Imaging Techniques
4.5.1. Imaging Techniques Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Genetic Testing
4.6.1. Genetic Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Cognitive Assessment Tests
4.7.1. Cognitive Assessment Tests Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 5. China Alzheimer’s Disease Diagnostics Market: Type Estimates & Trend Analysis
5.1. Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global China Alzheimer’s Disease Diagnostics Market by Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
5.5. Triage
5.5.1. Triage Market estimates and forecasts 2018 - 2030 (USD Million)
5.6. Diagnosis
5.6.1. Diagnosis Market estimates and forecasts 2018 - 2030 (USD Million)
5.7. Screening
5.7.1. Screening Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 6. China Alzheimer’s Disease Diagnostics Market: End Use Estimates & Trend Analysis
6.1. End Use Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global China Alzheimer’s Disease Diagnostics Market by End Use Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 - 2030 for the following
6.5. Hospitals
6.5.1. Hospitals Market estimates and forecasts 2018 - 2030 (USD Million)
6.6. Diagnostic Laboratories
6.6.1. Diagnostic Laboratories Market estimates and forecasts 2018 - 2030 (USD Million)
6.7. Academic and Research Institutes
6.7.1. Academic and Research Institutes Market estimates and forecasts 2018 - 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Quest Diagnostics
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Services benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Labcorb
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Services benchmarking
7.3.5.4. Strategic initiatives
7.3.6. F. Hoffmann-La Roche Ltd.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Services benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Siemens Healthineers
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Services benchmarking
7.3.7.4. Strategic initiatives
7.3.8. C2N diagnostics
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Services benchmarking
7.3.8.4. Strategic initiatives
7.3.9. FujireBio
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Services benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Bristol Myers Squibb
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Services benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Quanterix
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Services benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Sysmex
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Services benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Lantheus
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Services benchmarking
7.3.13.4. Strategic initiatives



List of Figures

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in APAC
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Alzheimer disease diagnostics market: market outlook
Fig. 10 Alzheimer disease diagnostics competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Alzheimer disease diagnostics market driver impact
Fig. 16 Alzheimer disease diagnostics market restraint impact
Fig. 17 Alzheimer disease diagnostics market strategic initiatives analysis
Fig. 18 Alzheimer disease diagnostics market: Diagnostics technique movement analysis
Fig. 19 Alzheimer disease diagnostics market: Diagnostics technique outlook and key takeaways
Fig. 20 Biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 CSF biomarkers estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Blood based biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Imaging techniques estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Genetic testing market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Cognitive assessment tests market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 26 Alzheimer disease diagnostics Market: Test type movement analysis
Fig. 27 Alzheimer disease diagnostics market: Test type outlook and key takeaways
Fig. 28 Triage market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Diagnosis market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 30 Screening market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 31 Alzheimer disease diagnostics market: End-users movement analysis
Fig. 32 Alzheimer disease diagnostics market: End-users outlook and key takeaways
Fig. 33 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Diagnostic laboratories market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 35 Academic and research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Market share of key market players- Alzheimer disease diagnostics market

List of Tables

List of Tables

Table 1 List of abbreviations
Table 2 China Alzheimer’s disease diagnostics market, by diagnostics technique, 2018 - 2030 (USD Million)
Table 3 China Alzheimer’s disease diagnostics market, by type, 2018 - 2030 (USD Million)
Table 4 China Alzheimer’s disease diagnostics market, by end use, 2018 - 2030 (USD Million)